tanshinone ii a has been researched along with calmidazolium in 1 studies
| Studies (tanshinone ii a) | Trials (tanshinone ii a) | Recent Studies (post-2010) (tanshinone ii a) | Studies (calmidazolium) | Trials (calmidazolium) | Recent Studies (post-2010) (calmidazolium) |
|---|---|---|---|---|---|
| 61 | 0 | 41 | 17 | 0 | 7 |
| Protein | Taxonomy | tanshinone ii a (IC50) | calmidazolium (IC50) |
|---|---|---|---|
| SUMO-1 | Homo sapiens (human) | 5.89 | |
| Apoptotic peptidase activating factor 1 | Homo sapiens (human) | 12.7 | |
| intestinal alkaline phosphatase precursor | Mus musculus (house mouse) | 14.6 | |
| caspase-9 isoform alpha precursor | Homo sapiens (human) | 7.14 | |
| ubiquitin-conjugating enzyme E2 N | Homo sapiens (human) | 8.2315 | |
| caspase-3 isoform a preproprotein | Homo sapiens (human) | 7.14 | |
| bcl-2-related protein A1 | Mus musculus (house mouse) | 6.23 | |
| Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 | Oryctolagus cuniculus (rabbit) | 0.5 | |
| Transcriptional activator protein LuxR | Aliivibrio fischeri | 7 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdeen, S; Chapman, E; Chitre, S; Hoang, QQ; Johnson, SM; Park, Y; Ray, AM; Salim, N; Sivinski, J; Stevens, M; Washburn, A | 1 |
1 other study(ies) available for tanshinone ii a and calmidazolium
| Article | Year |
|---|---|
HSP60/10 chaperonin systems are inhibited by a variety of approved drugs, natural products, and known bioactive molecules.
Topics: Biological Products; Chaperonin 10; Chaperonin 60; Escherichia coli; Humans; Inhibitory Concentration 50; Protein Folding; Rafoxanide; Salicylanilides; Suramin | 2019 |